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EL ÁCIDO ÚRICO SE ASOCIA CON
CARACTERÍSTICAS DE UN SÍNDROME
DE RESISTENCIA INSULÍNICA EN LOS NIÑOS
OBESOS EN ETAPAS PREPUBERALES
Resumen
Los niveles elevados de ácido úrico plasmáticos se aso-
cian a la obesidad y pueden ser la expresión de un estado de
resistencia insulínica. El objetivo de este estudio ha sido
evaluar la concentración plasmática de ácido úrico en niños
obesos y normales, exclusivamente en edad prepuberal, y
determinar su relación con las medidas antropométricas, la
ingesta dietética y los parámetros asociados al síndrome de
resistencia insulínica. El estudio se llevó a cabo en 34 niños
obesos y 20 controles en edad prepuberal a los cuales se les
estimó su ingesta dietética mediante el registro de un cues-
tionario de ingesta de alimentos de 72 h y un cuestionario de
frecuencia de consumo de alimentos y se determinaron,
además de los parámetros antropométricos, la glucosa, la
insulina, la leptina, la adiponectina y el factor de necrosis
tumoral alfa (TNF-α) plasmáticos. Se realizó un análisis de
regresión múltiple para identificar la asociación entre los
niveles de ácido úrico y los parámetros antropométricos, la
ingesta de nutrientes y las variables clásicas relacionadas
con el síndrome de resistencia insulínica (hipertensión, glu-
cosa, insulina, índice de resistencia insulínica HOMA, tri-
glicéridos y HDL-colesterol plasmáticos), así como con lep-
tina, adiponectina y TNF-α. La concentración plasmática
de ácido úrico fue significativamente más elevada en los
niños obesos que en los controles y, cuando se ajustó por
sexo, edad e índice de masa corporal, los niveles de ácido
úrico se asociaron con el pliegue tricipital y la resistencia
inulínica, y negativamente con la adiponectina. En el análi-
sis de regresión múltiple, el índice de masa corporal, el
HDL-colesterol y la adiponectina fueron predictores inde-
pendientes del ácido úrico plasmático. En conclusión, los
niveles elevados de ácido úrico en niños obesos en edad pre-
puberal, comparado con los de los niños normales, repre-




Palabras clave: Adipoquinas. Obesidad infantil. Síndrome
de resistencia insulínica. Ácido úrico.
Abstract
Elevated plasma uric acid levels are associated with obe-
sity and could be an expression of insulin-resistant state.
The aim of the present study was to evaluate plasma uric
acid in obese and normal-weight children exclusively at pre-
pubertal stage and its relationship with anthropometric
measurements, intake, and features of the insulin resistance
syndrome. A study was performed in 34 obese and 20 nor-
mal-weight prepubertal children. Nutrient intake was
determined using a 72 h recall questionnaire and a con-
sumption food frequency questionnaire. Anthropometric
parameters and fasting plasma lipids, glucose, insulin, lep-
tin, adiponectin, tumour necrosis factor (TNF-α) and uric
acid were measured. Multiple regression analysis was used
to identify association of anthropometric parameters, nutri-
ent intake and insulin resistance syndrome variables (arter-
ial blood pressure, plasma glucose, insulin, homeostasis
model assessment of insulin resistance index- HOMA- tria-
cylglycerols and, HDL-cholesterol) with uric acid. Plasma
uric concentration was significantly higher in the obese
group than in the control group and when adjusted by sex,
age and BMI was positively associated with tricipital skin-
fold and insulin resistance, and negatively with adiponectin.
In multiple regression analysis, BMI, HDL-cholesterol and
adiponectin were independent predictors of plasma uric
acid. In conclusion, elevated levels of uric acid in obese chil-
dren, compared with lean subjects, at the prepubertal
period, seems to be an early metabolic alteration that is asso-
ciated with other features of insulin resistance syndrome.
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Uric acid is the main product of purine metabolism and
is formed from xanthine by the action of xanthine oxidase.
Normal serum uric acid levels are generally 6.5-7 mg/100
ml for men, and 6-6.5 mg/100 ml for women, frequently
expressed as mg %. The limit of uric acid solubility in
extracellular fluids is 7.0 mg/dl, and patients with higher
serum concentrations are considered hyperuricemic.1
Uric acid is primarily excreted via the kidney, where it is
completely filtered at the glomerulus, fully reabsorbed into
the proximal tubule, and then secreted (about 50% of the
filtered load) and again reabsorbed. Elevated serum uric
acid concentrations can result from an overproduction of
uric acid but are usually the consequence of its low excre-
tion. High serum uric acid levels are associated with alco-
hol intake, a purine-rich diet, compromised renal function,
and obesity. Insulin increases both sodium and uric acid
reabsorption.2 Therefore, increased serum uric acid levels
may be an expression of an insulin-resistant state and
metabolic syndrome (MS). This proposition is supported
by evidence that higher serum uric acid levels correlate
with a lower insulin-stimulated glucose uptake and a
higher plasma insulin response to oral glucose loading.1
Although the cause of uric acid elevation has not yet
been elucidated, it might be explained by a mechanism
that involves high levels of extracellular adenosine
(Ado), as stated by Bakker and his coworkers.3 More-
over, an elevated synthesis of fatty acid-acyl-CoA in
peripheral tissues will result in a greater formation of
AMP and hence in higher levels of uric acid.3 We have
recently reported in the same obese population of the pre-
sent work elevated plasma levels of fatty acids,4 which
would condition higher levels of acyl-CoA in peripheral
tissues and therefore a potential elevation of uric acid.
Elucidation of the relationship between serum uric
acid and obesity or cardiovascular disease is complicated
by the numerous variables (i.e., hyperlipidemia, hyper-
tension, and hyperglycemia) reported to correlate with
both cardiovascular disease and hyperuricemia.5,6 Ele-
vated acid uric concentrations have even been described
as an independent risk factor for non-alcoholic fatty liver
disease. Furthermore, one study has indicated that uric
acid may be a reliable indicator of “pre-metabolic syn-
drome” in obese youths.7 However, as far as we know, no
data have been reported in obese children exclusively at
prepubertal age. Thus, the aim of this study was to deter-
mine plasma uric acid in obese and lean prepubertal chil-
dren and its relationships with anthropometric measure-
ments, dietary intake, and parameters related to the
insulin resistance syndrome (IRS). 
Subjects and methods
Study Population
We studied a selected group of 34 obese (23 boys
and 11 girls) and 20 normal-weight (11 boys and 9
girls) Caucasian Spanish children, recruited from
among children referred to our Paediatric Endocrinol-
ogy Unit from primary care paediatric clinics. Inclu-
sion criteria were: apparent good state of health, age
between 6-12 years, and classification as prepubertal
(Tanner I) based on Tanner criteria8 and validated by
appropriate plasma sex hormone concentrations
(results not shown). Exclusion criteria for both groups
were: presence of pubertal development, disease, or
malnutrition, use of medication that alters blood pres-
sure or glucose or lipid metabolism, and consumption
of hypocaloric diet. The groups (obese and normal-
weight) were matched by age and sex. 
Children were classified as obese if their body-mass
index (BMI) exceeded the 97th percentile for their age
and sex according to Spanish standards (BMI z score ≥
2.0).9 Children were classified as normal-weight if
their BMI was higher than the 5th and lower than the 75th
percentile.9 Both obese and normal-weight children
were also classified with IOFT reference10 showing a
hundred per cent of concordance with the classification
based on Spanish standards. The demographic and
anthropometric characteristics of both groups are
shown in table I. 
The study was approved by the Human Investigation
and Ethics Committees of the University of Granada
and the Reina Sofia University Hospital of Cordoba
(Spain). Written informed consent was obtained from
parents and verbal approval from children. 
Anthropometric, blood pressure measurements 
and dietary intake estimation
Anthropometric measurements children were bare-
footed and in their underwear. Body weight (kg) was
measured using a standard beam balance (Seca), preci-
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Table I
Baseline demographic and anthropometric characteristics
of the obese and normal weight prepubertal children
Obese (n = 34) Normal weight (n = 20)
Mean SEM Mean SEM
Age (years) 9.4 0.4 9.8 0.4
Weight (kg) 59.6 2.7* 29.1 1.1
Height (cm) 141.7 2.1* 131.6 1.8
Body mass index (kg/m2) 29 1* 17 0
Body mass index z score 4.05 0.30* -0.99 0.39
Waist circumference (cm) 88.5 2.2* 59.5 1.3
Tricipital skinfold (mm) 26.1 0.8* 8.7 1.0
Subscapular skinfold (mm) 30.2 1.1* 6.7 1.0
Fat mass (%) 34.2 2.2* 14.9 2.2
Values are expressed as means ± SEM.
Comparisons of demographic and anthropometric variables between obese and con-
trol children, with adjustments for age and sex, were assessed with general linear
models of variance. Significant differences between obese and controls: *P < 0.001.
sion 100 g, range 0-150 kg. Height (cm): using a preci-
sion stadiometer (Seca), precision 0,2 cm, range 70-
200 cm. Skinfold thicknesses (mm) were measured at
the left side of the body to the nearest 0.1 mm with a
skinfold caliper (Holtain, U.K., range 0-40 mm). The
measurements were taken at the following sites: Tri-
ceps, halfway between the acromion process and the
olecranon process at the back side of the arm; and sub-
scapular, about 20 mm below the tip of the scapula, at
an angle of 45° to the lateral side of the body. Body fat
mass was estimated from tricipital (TS) and subscapu-
lar (SS) skinfold measurements using validated equa-
tions.11,12 Waist circumference (WC) was measured
with an unelastic tape, precision 0.1 cm, range 0-150
cm, the subject in a standing position; the tape was
applied horizontally midway between the lowest rib
margin and the iliac crest about the level of the umbili-
cus, at the end of gentle expiration. 
Blood pressure was measured with a random-zero
sphygmomanometer. The cuff size (bladder-size) was
sufficiently long to surround at least two thirds of the
upper arm. The centre of the inflatable part of the cuff
(bladder) was positioned over the brachial artery of the
inner side of the upper arm. The blood pressure was
measured after resting with no change of position for at
least 5 minutes, in a sitting position and using the right
arm-unless there was a deformity.
Dietary intake was estimated using a previously val-
idated food-frequency questionnaire and a 72 h dietary
survey and a database for composition of Spanish
foods13 (table II).
Sampling
Baseline blood samples were obtained from children
while they were fasting, using an indwelling venous
line to draw a 3-ml sample for the measurement of
plasma levels of glucose, insulin, lipids, adipokines
(leptin, adiponectin and tumour necrosis factor) and
sex hormones (follicle stimulant hormone —FSH—,
lutein hormone —LH—, estradiol, and testosterone).
All samples were processed within 2 h of sampling and
divided into aliquots for immediate analysis or long-
term storage at -80 °C until their analysis.
Biochemical analysis
Glucose was analyzed by the glucose oxidase
method using an automatic analyzer (Roche-Hitachi
Modular PyD Autoanalyser, Roche Laboratory Sys-
tems, Mannheim, Germany), and plasma insulin and
C-peptide were analyzed by radioimmunoassay with
an automatic analyzer for microparticles (Axsym,
Abbott Laboratories, Chicago, IL, USA). Insulin resis-
tance was calculated by means of the homeostasis
model assessment (HOMA) index, defined by the
equation HOMA = fasting glucose (G
0
) (mM) x fasting
insulin (I
0
) (U/mL)/22.5.14 Sex hormones (FSH, LH,
testosterone and estradiol) were measured by chemio-
luminescence using an automatic analyzer (Architet
I4000, Abbott Laboratories Chicago, IL, USA).
Plasma urate, triacylglycerols (TAG), high-density
lipoprotein cholesterol (HDL-cholesterol), and
apoprotein B (Apo B) levels were measured by means
of an automatic analyzer (Roche-Hitachi Modular PyD
Autoanalyser, Roche Laboratory Systems, Mannheim,
Germany). Plasma adiponectin levels were measured
by using a human adiponectin radioimmunoassay
(RIA) kit (Cat.#HADP-61HK, Linco Research Inc. St.
Charles, MO, USA), and plasma leptin and tumor
necrosis factor-alfa (TNF-α) levels were measured by
means of ELISAs (Cat.#KAC2282/KAC2281, Cat.
#KHC3011C, Biosource Europe SA, Nivelles, Bel-
gium).
Statistical analysis
The minimum sample size to detect a significant ele-
vation of uric acid (type I error α = 0.05 and a type II
error β = 0.2 -power 80%) was estimated to be 20 chil-
dren per group, based on a minimal difference of 20%
between obese and lean subjects and considering vari-
ances previously obtained for healthy children. 
Data are expressed as means ± standard error of the
mean (SEM). Variables with an abnormal distribution
(insulin, HOMA) were log-transformed before analy-
sis. General linear models of variance, adjusted for age
and sex, were used to compare demographic, dietary
intake and clinical variables between obese and control
children. Pearson’s correlation coefficients were used
to study correlations between uric acid and dietary
intake of major nutrients, anthropometric, metabolic
and adipokine variables. Since co-linearity may occur
for BMI and these parameters associated with obesity,
linear correlations were adjusted by age, sex and BMI.
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Table II
Estimated daily nutrient intakes in obese and normal
weight children at prepubertal age
Obese (n = 34) Normal weight (n = 20)
Nutrient intake
g/d % of energy g/d % of energy
Energy (kcal/d) 2,037 ± 65** 100 1,601 ± 82 100
Proteins (g/d) 84 ± 3** 16.5 ± 0.6 64 ± 4 16.0 ± 1.0
Carbohydrates (g/d) 222 ± 10* 43.6 ± 2.0 181 ± 10 45.2 ± 2.5
Fat (g/d) 93 ± 4** 41.1 ± 1.8 70 ± 4 39.3 ± 2.2
Saturated (g/d) 30.6 ± 1.3** 13.5 ± 0.6 25.7 ± 1.4 14.4 ± 0.8
Monounsaturated (g/d) 47.1 ± 2.6** 20.8 ± 1.1 34.3 ± 2.9 19.3 ± 1.6
Polyunsaturated (g/d) 15.3 ± 1.3** 6.8 ± 0.6 10.0 ± 1.4 5.6 ± 0.8
Values are expressed as means ± SEM.
Comparison of nutrient’s intake between obese and control children, with adjust-
ments for age and sex, were assessed with general linear models of variance. Sig-
nificant differences between obese and controls: *P < 0.05; **P < 0.001.
In addition, multiple regression analyses were per-
formed to identify predictor variables of uric acid asso-
ciated with the classical features of metabolic syn-
drome. SPSS software (version 13.0, SPSS Inc.
Chicago, IL, USA) was used for the analyses. 
Results
BMI, TS, SS, WC, and percentage fat mass were sig-
nificantly higher in the obese group compared with the
control group (table I). In addition, obese children had
a significant higher intake of energy and major nutri-
ents compared with normal-weight children (table II).
Table III shows the blood pressure and the biochemical
parameters related to the IRS in obese and normal-
weight children. SBP, DBP, insulin, HOMA, C-pep-
tide, TAG, Apo B and leptin were higher in the obese
group compared with the control group, whereas HDL-
cholesterol and adiponectin were lower and TNF-α
were similar. Serum creatinine and glomerular filtra-
tion rate were in the normal range in both groups (result
not shown). Plasma uric concentrations were signifi-
cantly higher in the obese children than in the normal-
weight controls (table III). 
There was a positive association between plasma
uric acid levels and anthropometric parameters, with
TS showing the strongest correlation (table IV). In
relation to diet, uric acid levels were correlated with the
intake of energy, proteins, carbohydrates, and monoun-
saturated and polyunsaturated fats (table IV). How-
ever, when nutrient intakes were adjusted by sex, age
and BMI no significant correlations with uric acid were
found. SBP, DBP as well as plasma insulin and C-pep-
tide concentrations were positively correlated with
plasma uric acid levels and hence with the HOMA
index. Likewise, uric acid was positively correlated
with TAG and apo B and negatively correlated with
HDL-cholesterol. Moreover, uric acid was positively
correlated with leptin and negatively correlated with
adiponectin and TNF-α (table IV).
Since univariate correlations between uric acid and
any other parameters such as blood pressure, plasma
lipids and glucose metabolism parameters may just
explained by the fact that uric acid concentrations as
well as those parameters are both related to BMI, we
performed linear regression analyses adjusted by age,
sex and BMI. With this approach, only TS, HOMA and
adiponectin were significantly correlated with plasma
uric acid (table V).
In a backward stepwise multiple correlation analysis
that included the known features of IRS (BMI, SBP,
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Table III
Baseline blood pressure and biochemical characteristics
of the obese and normal weight prepubertal children
Obese (n = 34) Normal weight (n = 20)
Mean SEM Mean SEM
Systolic blood pressure 110 3* 95 1(mmHg)
Diastolic blood pressure 60 2* 49 2(mmHg)
Glucose (mg/dl) 86 1 90 2
Insulin (U/l) 13.6 1.5* 5.7 0.8
C-peptide (μmol/l) 1.1 0.1* 0.3 0.0
HOMA 2.86 0.32* 1.30 0.19
Triacylglycerols (mg/dl) 86.71 6.64* 53.15 5.57
HDL-cholesterol (mg/dl) 50.76 1.83* 70.25 3.19
Apoprotein B (mg/dl) 74.44 3.08* 61.95 1.70
Uric acid (mg/dl) 5.2 0.2* 3.8 0.2
Leptin (ng/l) 30.70 2.8* 7.0 1.1
Adiponectin (mg/l) 28.51 1.86* 44.36 3.55
Tumour necrosis factor-α 49.5 3.7 57.8 3.4(ng/l)
Values are expressed as means ± SEM.
Comparisons of blood pressure and biochemical variables between obese and con-
trol children, with adjustments for age and sex, were assessed with general linear
models of variance. Significant differences between obese and controls: *P < 0.001.
Table IV
Correlations between different variables (nutrients,
anthropometric parameters, biochemical paramenters
and adipokines) and plasma uric acid levels in obese
and normal weight prepubertal children
Variables correlated with uric acid R P
BMI (kg/m2) 0.550 < 0.001
Tricipital skinfold (mm) 0.715 < 0.001
Subscapular skinfold (mm) 0.892 < 0.001
Waist circumference (cm) 0.625 < 0.001
Fat mass (%) 0.600 < 0.001
Energy intake (kcal/d) 0.392 0.004
Protein intake (g/d) 0.400 0.003
Carbohydrate intake (g/d) 0.396 0.004
MUFA intake (g/d) 0.338 0.014
PUFA intake (g/d) 0.497 < 0.001
Insulin (U/l) 0.315 0.022
C-peptide (μmol/l) 0.414 0.004
HOMA 0.277 0.044
Systolic blood pressure (mmHg) 0.451 0.001
Diastolic blood pressure (mmHg) 0.284 0.050
Triacylglycerols (mg/dl) 0.276 0.043
Apoprotein B (mg/dl) 0.360 0.007
HDL-cholesterol (mg/dl) -0.510 < 0.001
Leptin (ng/l) 0.424 0.001
Adiponectin (mg/l) -0.450 0.001
Tumour necrosis factor-alfa (ng/l) -0.346 0.027
HOMA: homeostasis model assessment index; 
r: Pearson correlation coefficient; P: probability. Obese (n: 34) vs
controls (n: 20).
In all correlations when the variables did not follow a normal distrib-
ution log transformed values were used.
TAG, c-HDL, and insulin), BMI and c-HDL were good
predictors of plasma uric acid levels (table V). When
adiponectin was incorporated into the multiple regres-
sion model it was also independently associated with
uric acid (table V). 
Discussion
The prepubertal obese children in this study had
higher plasma uric acid concentrations compared with
their normal-weight peers, although none of them were
hyperuricemic. Plasma uric acid showed a positive cor-
relation with anthropometric parameters and with the
main characteristics described for the IRS in child-
hood.15
Uric acid arises from purine metabolism and can
increase with a higher intake of nucleic acid-rich food,
which also has high protein content. We found a positive
correlation between plasma uric acid and energy and
macronutrient intakes in this study; therefore a high pro-
tein intake might in part explain the elevated plasma uric
acid levels in the obese patients. Nevertheless, the high
uric acid levels in these prepubertal children are more
likely to result from a combination of high BMI and
metabolic disorders, i.e., hyperinsulinaemia, insulin
resistance and dyslipidaemia, as indicated by the present
finding of a positive association of BMI, insulin, HOMA
and TAG and a negative association of HDLc with uric
acid. In fact, uric acid was independently associated with
BMI, HDLc and adiponectin.
The association between obesity and hyperuricemia
is well documented in both adults and mixed popula-
tions of adolescents and children; in adults, hyper-
uricemia is considered a common obesity- and MS-
related “lifestyle” disorder and might be useful as an
indicator of metabolic derangement in obesity from
early adolescence onwards.16-18
In normal-weight children, plasma uric acid
increases significantly at the end of puberty, due to a
lower renal clearance of it. However, in obese children
renal clearance decreases at the beginning of puberty,
with a progressive increase in plasma uric acid as
puberty advances, which may at least in part be due to
uric acid overproduction.19 The present study suggests
that obesity in prepubertal age may bring forward
changes in uric acid metabolism which are usually
observed at puberty. 
There have been reports that 23-25% of obese chil-
dren present at least three MS components.20 Uric acid
is one of the non-traditional risk factors for MS.20 How-
ever, few studies have addressed the relationship of
serum uric acid levels with obesity and the IRS in chil-
dren and adolescents20,21 and no reports have been pub-
lished exclusively at the prepubertal period. In a study
of hyperuricemia in normal-weight children, Oyama et
al, 200617 found an incidence of 8.8% in boys and 0.6%
in girls. Another study found that 80.4% of severely
obese children had at least one MS complication,
including elevated uric acid.22 Results obtained in the
present study show a correlation between uric acid lev-
els in obese prepubertal children and some risk factors
for the MS (table IV). In another study in adults, uric
acid also appeared to be correlated with obesity, blood
pressure, TAG, insulin, HOMA and adiponectin,
underscoring its impact on the IRS6 and it has also been
suggested that hyperuricemia in obesity can be affected
by fat mass distribution,23 testosterone,7 or leptin.24 In
the present study with obese children at early age,
adiponectin, a well known adipokine involved in the
regulation of insulin signalling and a key factor in IRS
and cardiovascular disease,25 was independently asso-
ciated with uric acid, which emphasised the potential
role of this hormone in IRS and subsequently in uric
acid elevation.
A potential mechanism to explain the increased levels
of plasma uric acid in plasma is the rise in intracellular
Ado, derived of the higher AMP concentrations associ-
ated to increased synthesis of fatty acid-acyl-CoA in
peripheral tissues.3 As stated before, we have found ele-
vated plasma levels of fatty acids in obese children4,
which would condition higher levels of acyl-CoA in
peripheral tissues and therefore a rise in plasma uric
acid. Thus, we propose that in early obesity increased
levels of uric acid are related to elevated plasma fatty
acids (fig. 1). The mitochondrial adenine nucleotide
translocator (ANT) serves to supply the mitochondrial
matrix with cytosolic ADP and also to supply the cytosol
with ATP produced from ADP in the mitochondrial
matrix. Hence, inhibition of ANT by elevated intracellu-
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Table V
Correlations between different anthropometric and
metabolic variables and plasma uric acid levels
in obese and normal weight prepubertal children
adjusted by sex age and BMI, and backward stepwise
multiple regression analysis of uric acid and features
of metabolic syndrome
Correlations with plasma uric acid
Pearson P
coefficient value
Tricipital skinfold (mm) 0.670 0.006
HOMA 0.499 0.050 
Adiponectin (mg/l) -0.590 0.021
Predictor variables of plasma uric β standardised P
acid associated with the IRS* coefficient value
BMI (kg/m2) 0.368 0.014
HDLc (mg/dl) -0.358 0.017
Adiponectin (mg/l) -0.382 0.004 
Obese (n: 34) vs controls (n: 20).
*For multiple regression analysis adjusted values for sex and age of
BMI, systolic blood pressure, plasma glucose, insulin, triacylglycerols
and HDL-cholesterol were included as classical characteristics of the
IRS (R2 of the model: 0.425). When adiponectin was included into
the model, R2: 0.547.
HOMA: homeostasis model assessment index; IRS: insulin resis-
tance syndrome.
lar LCFA-CoA concentrations, derived from the obese
state, would result in an excess of cytosolic ADP and a
parallel decrease in cytosolic ATP concentrations. Con-
sequently, cytosolic adenylate kinase shifts towards pro-
duction of one molecule of ATP and one molecule of
AMP from two molecules of ADP. This rise in cytosolic
AMP concentration increases dephosphorylation of
AMP to Ado. This increase in Ado impairs equilibrative
transport from the extracellular space because of a lower
concentration gradient, resulting in higher plasma Ado
and urate concentrations.3 Moreover, an elevated syn-
thesis of fatty acid-acyl-CoA in peripheral tissues will
result in a greater formation of AMP and hence in higher
levels of uric acid.
Various hypotheses have been proposed for the role
of uric acid in the early pathogenesis of primary (idio-
pathic) hypertension and vascular disease. In animal
experiments, modest increases in plasma uric acid pro-
duced subtle glomerulotubular damage that activated the
renin-angiotensin system and increased blood pressure,
all reversed by removal of the hyperuricemic stimulus.26
Elevated serum uric acid also plays a part in endothelial
dysfunction, both directly and indirectly via xanthine
oxidase activity, which is elevated in atherosclerotic
plaques.27 Oxidative stress produced by the generation of
oxygen free radicals, limiting the availability of nitric
oxide, reduces endothelial-regulated vascular relax-
ation. Moreover, free radicals formed in hyperuricemia
also stimulate lipid peroxidation, which might be
responsible for increasing carotid intima-media thick-
ness.28 Other potential mechanisms by which hyper-
uricemia and/or elevated xanthine oxidase activity
might produce vascular damage include increased
platelet adhesiveness, smooth muscle cell proliferation,
and stimulation of inflammatory responses.28
Studies in children have related uric acid to blood
pressure.5,29 Children with primary hypertension are fre-
quently obese and have elevated serum uric acid levels.30
Consequently, some authors have proposed that obese
and hypertensive children should be screened for MS
components in order to initiate early prevention mea-
sures against cardiovascular disease.30 Based on the
present study findings in prepubertal obese children in
which arterial pressure was significantly higher than in
the controls and positively correlated with uric acid
levels, we propose that plasma uric acid should also be
assessed for this purpose.
In conclusion, plasma uric acid elevation in prepuber-
tal obese children is associated with IRS features and
BMI, HDL-cholesterol and adiponectin are indepen-
dently associated with uric acid levels. We suggest that
uric acid is an early marker of the excess of body weight
and a key link in MS in prepubertal obese children. 
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Fig. 1.—Proposed mecha-
nism to explain increased
uric acid in insulin resistan-
ce in childhood obesity.
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